Up-Regulation of the cardiac lipid metabolism at the onset of heart failure

Cardiovascular and Hematological Agents in Medicinal Chemistry

Volumn 9, Issue 3, 2011, Pages 190-206

  AbdAlla, Said ^a   Fu, Xuebin ^a   Elzahwy, Sherif S ^b   Klaetschke, Kristin ^c   Streichert, Thomas ^c   Quitterer, Ursula ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Saint Fatima Square Heliopolis   (Egypt)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Aortic constriction; Atherosclerosis; Heart failure; Lipid metabolism; Microarray gene expression analysis; Pressure overload; Ranolazine

Indexed keywords

CYSTAMINE; FATTY ACID SYNTHASE; RANOLAZINE; TRIACYLGLYCEROL;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; ATHEROSCLEROSIS; CELL DEATH; CELL RESPIRATION; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION PROFILING; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PATHOGENESIS; UPREGULATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; AORTIC DISEASES; ATHEROSCLEROSIS; HEART FAILURE; HUMANS; LIPID METABOLISM; MICE; MYOCARDIUM; OXYGEN CONSUMPTION; UP-REGULATION;

EID: 80052236456     PISSN: 18715257     EISSN: 18756182     Source Type: Journal    
DOI: 10.2174/187152511797037583     Document Type: Article

References (49)

1. Kannel, W.B. Incidence and epidemiology of heart failure. Heart Fail. Rev., 2000, 5(2), 167-173.
2. Neubauer, S. The failing heart--an engine out of fuel. N. Engl. J. Med., 2007, 356(11), 1140-1151.
3. Ingwall, J.S.; Weiss, R.G. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ. Res., 2004, 95(2), 135-145.
4. Ashrafian, H.; Frenneaux, M.P.; Opie, L.H. Metabolic mechanisms in heart failure. Circulation, 2007, 116(4), 434-448.
5. Opie, L.H.; Knuuti, J. The adrenergic-fatty acid load in heart failure. J. Am. Coll. Cardiol., 2009, 54(18), 1637-1646.
6. van Bilsen, M.; van Nieuwenhoven, F.A.; van der Vusse, G.J. Metabolic remodelling of the failing heart: beneficial or detrimental. Cardiovasc. Res., 2009, 81(3), 420-428.
7. Murray, A.J.; Cole, M.A.; Lygate, C.A.; Carr, C.A.; Stuckey, D.J.; Little, S.E.; Neubauer, S.; Clarke, K. Increased mitochondrial uncoupling proteins, respiratory uncoupling and decreased efficiency in the chronically infarcted rat heart. J. Mol. Cell. Cardiol., 2008, 44(4), 694-700.
8. Murray, A.J.; Anderson, R.E.; Watson, G.C.; Radda, G.K.; Clarke, K. Uncoupling proteins in human heart. Lancet, 2004, 364(9447), 1786-1788.
9. Vettor, R.; Fabris, R.; Serra, R.; Lombardi, A.M.; Tonello, C.; Granzotto, M.; Marzolo, M.O.; Carruba, M.O.; Ricquier, D.; Federspil, G.; Nisoli, E. Changes in FAT/CD36, UCP2, UCP3 and GLUT4 gene expression during lipid infusion in rat skeletal and heart muscle. Int. J. Obes. Relat. Metab. Disord., 2002, 26(6), 838-847.
10. Palaniswamy, C.; Mellana, W.M.; Selvaraj, D.R.; Mohan, D. Metabolic modulation: A new therapeutic target in treatment of heart failure. Am. J. Ther., 2010, Apr. 10 [E-pub ahead of print].
11. Wu, J.H.; Hagaman, J.; Kim, S.; Reddick, R.L.; Maeda, N. Aortic constriction exacerbates atherosclerosis and induces cardiac dysfunction in mice lacking apolipoprotein E. Arterioscler. Thromb. Vasc. Biol., 2002, 22(3), 469-475.
12. Sahn, D.J.; DeMaria, A.; Kisslo, J.; Weyman, A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation, 1978, 58(6), 1072-1083.
13. Abd Alla, J.; Langer, A.; Elzahwy, S.S.; Arman-Kalcek, G.; Streichert, T.; Quitterer, U. Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis. J. Biol. Chem., 2010, 285(30), 23496-23505.
14. Folch, J.; Lees, M.; Sloane, S.G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 1957, 226(1), 497-509.
15. Lorenz, K.; Lohse, M.J.; Quitterer, U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature, 2003, 426(6966), 574-579.
16. AbdAlla, S.; Lother, H.; el Missiry, A.; Langer, A.; Sergeev, P.; el Faramawy, Y.; Quitterer, U. Angiotensin II AT2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease. J. Biol. Chem., 2009, 284(10), 6554-6565.
17. AbdAlla, S.; Lother, H.; Langer, A.; el Faramawy, Y.; Quitterer, U. Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis. Cell, 2004, 119(3), 343-354.
18. Kannel, W.B.; DAgostino, R.B.; Sullivan, L.; Wilson, P. W. Concept and usefulness of cardiovascular risk profiles. Am. Heart. J., 2004, 148(1), 16-26.
19. Kassiri, Z.; Oudit, G.Y.; Sanchez, O.; Dawood, F.; Mohammed, F.F.; Nuttall, R.K.; Edwards, D.R.; Liu, P.P.; Backx, P.H.; Khokha, R. Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice. Circ. Res., 2005, 97(4), 380-390.
20. Kuba, K.; Zhang, L.; Imai, Y.; Arab, S.; Chen, M.; Maekawa, Y.; Leschnik, M.; Leibbrandt, A.; Markovic, M.; Schwaighofer, J.; Beetz, N.; Musialek, R.; Neely, G.G.; Komnenovic, V.; Kolm, U.; Metzler, B.; Ricci, R.; Hara, H.; Meixner, A.; Nghiem, M.; Chen, X.; Dawood, F.; Wong, K.M.; Sarao, R.; Cukerman, E.; Kimura, A.; Hein, L.; Thalhammer, J.; Liu, P.P.; Penninger, J.M. Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload. Circ. Res., 2007, 101(4), e32-e42.
21. Frankel, D.S.; Vasan, R.S.; D'Agostino, R.B.; Benjamin, E.J.; Levy, D.; Wang, T.J.; Meigs, J.B. Resistin, adiponectin, and risk of heart failure the Framingham offspring study. J. Am. Coll. Cardiol., 2009, 53(9), 754-762.
22. McGovern, P.G.; Pankow, J.S.; Shahar, E.; Doliszny, K.M.; Folsom, A.R.; Blackburn, H.; Luepker, R.V. Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N. Engl. J. Med., 1996, 334(14), 884-890.
23. Rosen, B.D.; Cushman, M.; Nasir, K.; Bluemke, D.A.; Edvardsen, T.; Fernandes, V.; Lai, S.; Tracy, R.P.; Lima, J.A. Relationship between C-reactive protein levels and regional left ventricular function in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis. J. Am. Coll. Cardiol., 2007, 49(5), 594-600.
24. Brookheart, R.T.; Michel, C.I.; Schaffer, J.E. As a matter of fat. Cell. Metabol., 2009, 10(1), 9-12.
25. van der Vusse, G.J.; Glatz, J.F.; Stam, H.C.; Reneman, R.S. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol. Rev., 1992, 72(4), 881-940.
26. Olivetti, G.; Abbi, R.; Quaini, F.; Kajstura, J.; Cheng, W.; Nitahara, J.A.; Quaini, E.; Di Loreto, C.; Beltrami, C.A.; Krajewski, S.; Reed, J.C.; Anversa, P. Apoptosis in the failing human heart. N. Engl. J. Med., 1997, 336(16), 1131-1141.
27. de Vries, J.E.; Vork, M.M.; Roemen, T.H.; de Jong, Y.F.; Cleutjens, J.P.; van der Vusse, G.J.; van Bilsen, M. Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. J. Lipid Res., 1997, 38(7), 1384-1394.
28. Jayakumar, A.; Tai, M.H.; Huang, W.Y.; al-Feel, W.; Hsu, M.; Abu-Elheiga, L.; Chirala, S.S.; Wakil, S.J. Human fatty acid synthase: properties and molecular cloning. Proc. Natl. Acad. Sci. USA, 1995, 92(19), 8695-8699.
29. Morrow, D.A.; Scirica, B.M.; Karwatowska-Prokopczuk, E.; Murphy S.A.; Budaj, A.; Varshavsky S.; Wolff, A.A.; Skene, A.; McCabe, C.H.; Braunwald, E.; MERLIN-TIMI 36 Trial Investigators. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. JAMA, 2007, 297(16), 1775-1783.
30. Skrede, S. Effects of cystamine and cysteamine on the adenosine& triphosphatase activity and oxidative phosphorylation of rat-liver mitochondria. Biochem. J., 1966, 98(3), 702-710.
31. Skrede, S. A permeability barrier in mitochondria in 'high-energy states' against positively charged disulphides. Biochem. J., 1968, 107(5), 645-654.
32. Dedeoglu, A.; Kubilus, J.K.; Jeitner, T.M.; Matson, S.A.; Bogdanov, M.; Kowall, N.W.; Matson, W.R.; Cooper, A.J.; Ratan, R.R.; Beal, M.F.; Hersch, S.M.; Ferrante, R.J. Therapeutic effects of cystamine in a murine model of Huntington' s disease. J. Neurosci., 2002, 22(20), 8942-8950.
33. Linzbach, A.J. Vacuolar fatty degeneration of the myocardial fibers. Virchows Arch., 1952, 321(6), 611-622.
34. Fournier, N. C. Uptake and transport of lipid substrates in the heart. Basic Res. Cardiol., 1987, 82(Suppl. 1), 11-18.
35. Gercken, G.; Trotz, M. Fatty acid synthesis in the arrested rabbit heart during ischemia. Pflugers Arch., 1983, 398(1), 69-72
36. Gloster, J.; Harris, P. Effect of anaerobiosis on the incorporation of (14C)acetate into lipid in the perfused rat heart. J. Mol. Cell. Cardiol., 1972, 4(3), 213-228.
37. Dyntar, D.; Eppenberger-Eberhardt, M.; Maedler, K.; Pruschy, M.; Eppenberger, H.M.; Spinas, G.A.; Donath, M.Y. Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes. Diabetes, 2001, 50(9), 2105-2113.
38. Chiu, H.; Kovacs, A.; Ford, D.A.; Hsu, F.; Garcia, R.; Herrero, P.; Saffitz, J.E.; Schaffer, J.E. A novel mouse model of lipotoxic cardiomyopathy. J. Clin. Invest., 2001, 107(7), 813-822.
39. Cheng, L.; Ding, G.; Qin, Q.; Huang, Y.; Lewis, W.; He, N.; Evans, R.M.; Schneider, M.D.; Brako, F.A.; Xiao, Y.; Chen, Y.E.; Yang, Q. Cardiomyocyte-restricted peroxisome proliferatoractivated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat. Med., 2004, 10(11), 1245-1250.
40. Hendrickson, S.C.; St. Louis, J.D.; Lowe, J.E.; Abdelaleem S. Free fatty acid metabolism during myocardial ischemia and reperfusion. Mol. Cell. Biochem., 1997, 166(1-2), 85-94.
41. Walhaus, T.R.; Taylor, M.; DeGrado, T.R.; Russell, D.C.; Stanko, P.; Nickles, R.J.; Stone, C.K. Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Circulation, 2001, 103(20), 2441-2446.
42. Wagle, S.; Bui, A.; Ballard, P.L.; Shuman, H.; Gonzales, J.; Gonzales, L.W. Hormonal regulation and cellular localization of fatty acid synthase in human fetal lung. Am. J. Physiol., 1999, 277(2 Pt 1), L381-L390.
43. Cao, W.; Medvedev, A.V.; Daniel, K.W.; Collins, S. betaadrenergic activation of p38 MAP kinase in adipocytes: cAMP induction of the uncoupling protein 1 (UCP1) gene requires p38 MAP kinase. J. Biol. Chem., 2001, 276(29), 27077-27082.
44. Kim, S.; Dugail, I.; Standridge, M.; Claycombe, K.; Chun, J.; Moustaid-Moussa, N. Angiotensin II-responsive element is the insulin-responsive element in the adipocyte fatty acid synthase gene: role of adipocyte determination and differentiation factor 1/sterol-regulatory-element-binding protein 1c. Biochem. J., 2001, 357(Pt 3), 899-904.
45. Hongo, M.; Ishizaka, N.; Furuta, K.; Yahagi, N.; Saito, K.; Sakurai, R.; Matsuzaki, G.; Koike, K.; Nagai, R. Administration of angiotensin II, but not catecholamines, induces accumulation of lipids in the rat heart. Eur. J. Pharmacol., 2009, 604(1-3), 87-92.
46. MacDougald, O.A.; Lane, M.D. Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 1995, 64, 345-373.
47. Prusty, D.; Park, B.H.; Davis, K.E.; Farmer, S.R. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J. Biol. Chem., 2002, 277(48), 46226-46232.
48. Igwe, E.I.; Essler, S.; Al-Furoukh, N.; Dehne, N.; Brüne, B. Hypoxic transcription gene profiles under the modulation of nitric oxide in nuclear run on-microarray and proteomics. BMC Genomics, 2009, 10, 408.
49. Gupta, A.; Chacko, V.P.; Weiss, R.G. Abnormal energetic and ATP depletion in pressure-overload mouse hearts: in vivo high-energy phosphate concentration measures by noninvasive magnetic resonance. Am. J. Physiol. Heart Circ. Physiol., 2009, 297(1), H59-H64.